Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70]
Int J Cardiol. 2018 Jun 15:261:240.
doi: 10.1016/j.ijcard.2018.03.075.
Epub 2018 Mar 27.
1 Karolinska Institutet, Department of Medicine, Stockholm, Sweden. Electronic address: gianluigi.savarese@ki.se.
2 Département de Cardiologie & CIC-IT U 804, Centre, Hospitalier Universitaire de Rennes, France; LTSI, Université Rennes 1, INSERM, 1099, Rennes, France.
3 Karolinska Institutet, Department of Medicine, Stockholm, Sweden; Karolinska University Hospital, Department of Cardiology, Stockholm, Sweden.
4 INSERM, Clinical Investigation Center, CIC-1414 Rennes, France.
5 Karolinska Institutet, Department of Clinical Sciences Danderyd, Stockholm, Sweden; Danderyd Hospital, Department of Cardiology, Stockholm, Sweden.